|
|
|
Volumn 6, Issue 3, 1996, Pages 127-132
|
|
Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDOTE;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
CISPLATIN;
FLUOROURACIL;
FOLINIC ACID;
PACLITAXEL;
ADULT;
AGED;
BREAST TUMOR;
CLINICAL TRIAL;
DOSE RESPONSE;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METASTASIS;
MIDDLE AGED;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REVIEW;
ADULT;
AGED;
ANTIDOTES;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CISPLATIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FLUOROURACIL;
HUMANS;
INFUSIONS, INTRAVENOUS;
LEUCOVORIN;
MIDDLE AGED;
PACLITAXEL;
|
|
EID: 0030154533
PISSN: 10600051
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (34)
|
